Levels of omega-3 fatty acid in serum phospholipids and depression in patients with lung cancer.

PubWeight™: 0.77‹?›

🔗 View Article (PMC 2361538)

Published in Br J Cancer on December 12, 2005

Authors

M Kobayakawa1, S Yamawaki, K Hamazaki, T Akechi, M Inagaki, Y Uchitomi

Author Affiliations

1: Psycho-Oncology Division, National Cancer Center Research Institute East, 6-5-1 Kashiwanoha, Kashiwa-City, Chiba 277-8577, Japan.

Articles citing this

Depression in cancer patients: a critical review. Clin Pract Epidemiol Ment Health (2007) 1.22

Considerations regarding neuropsychiatric nutritional requirements for intakes of omega-3 highly unsaturated fatty acids. Prostaglandins Leukot Essent Fatty Acids (2009) 1.00

Articles cited by this

A rapid method of total lipid extraction and purification. Can J Biochem Physiol (1959) 173.74

The hospital anxiety and depression scale. Acta Psychiatr Scand (1983) 121.58

The prevalence of psychiatric disorders among cancer patients. JAMA (1983) 5.48

Fish consumption and major depression. Lancet (1998) 3.42

Is low dietary intake of omega-3 fatty acids associated with depression? Am J Psychiatry (2004) 2.01

Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry (2002) 1.98

Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial. Eur Neuropsychopharmacol (2003) 1.84

A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psychiatry (2002) 1.82

Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol Psychiatry (1998) 1.73

Depression in patients with cancer. Diagnosis, biology, and treatment. Arch Gen Psychiatry (1995) 1.72

Physiological compartmental analysis of alpha-linolenic acid metabolism in adult humans. J Lipid Res (2001) 1.68

Major depression is associated with lower omega-3 fatty acid levels in patients with recent acute coronary syndromes. Biol Psychiatry (2004) 1.56

Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. J Affect Disord (1998) 1.54

Fish consumption and depressive symptoms in the general population in Finland. Psychiatr Serv (2001) 1.42

Fatty acid composition in major depression: decreased omega 3 fractions in cholesteryl esters and increased C20: 4 omega 6/C20:5 omega 3 ratio in cholesteryl esters and phospholipids. J Affect Disord (1996) 1.40

Fatty acids in serum cholesteryl esters as quantitative biomarkers of dietary intake in humans. Am J Epidemiol (1997) 1.25

Lowered omega3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatry Res (1999) 1.24

The role of dietary n-6 and n-3 fatty acids in the developing brain. Dev Neurosci (2001) 1.22

Common psychiatric disorders in cancer patients. I. Adjustment disorders and depressive disorders. Support Care Cancer (1994) 1.20

Single measurement of serum phospholipid fatty acid as a biomarker of specific fatty acid intake in middle-aged Japanese men. Eur J Clin Nutr (2001) 1.15

Depression in cancer patients. Lancet Oncol (2001) 1.13

Treatment of depression in cancer. J Natl Cancer Inst Monogr (2004) 1.12

A data-based approach for designing a semiquantitative food frequency questionnaire for a population-based prospective study in Japan. J Epidemiol (1996) 1.11

Screening for psychological distress in Japanese cancer patients. Jpn J Clin Oncol (1998) 1.09

Reliability of fatty acid composition in human serum phospholipids. Eur J Clin Nutr (2000) 1.09

Polyunsaturated fatty acids in the food chain in Japan. Am J Clin Nutr (2000) 1.00

Daily omega-3 fatty acid intake and depression in Japanese patients with newly diagnosed lung cancer. Br J Cancer (2004) 0.95

Serum fatty acids and fish intake in rural Japanese, urban Japanese, Japanese American and Caucasian American men. Int J Epidemiol (1989) 0.93

Dieting, essential fatty acid intake, and depression. Nutr Rev (2000) 0.87

Plasma and erythrocyte membrane long chain polyunsaturated fatty acids in endogenous depression. Neurochem Int (1981) 0.79

Behavioral responses are altered in piglets with decreased frontal cortex docosahexaenoic acid. J Nutr (2003) 0.77

Articles by these authors

Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochemistry (1984) 10.83

Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur J Biochem (1997) 6.99

Phosphorylation of myosin-binding subunit (MBS) of myosin phosphatase by Rho-kinase in vivo. J Cell Biol (1999) 3.43

Identification of a novel phosphorylation site on histone H3 coupled with mitotic chromosome condensation. J Biol Chem (1999) 2.99

Requirement of phosphatidylinositol 4,5-bisphosphate for alpha-actinin function. Nature (1992) 2.62

An acutely confused 15-year-old girl. Lancet (1997) 2.52

Zyxin, a regulator of actin filament assembly, targets the mitotic apparatus by interacting with h-warts/LATS1 tumor suppressor. J Cell Biol (2000) 2.36

Site-specific phosphorylation induces disassembly of vimentin filaments in vitro. Nature (1987) 2.33

The circadian pattern of the development of ventricular fibrillation in patients with Brugada syndrome. Eur Heart J (1999) 2.28

Dynamic changes of 12-lead electrocardiograms in a patient with Brugada syndrome. J Cardiovasc Electrophysiol (1998) 2.19

Tissue-specific expression of three distinct types of rabbit protein kinase C. Nature (1987) 2.14

Rho-kinase/ROCK is involved in cytokinesis through the phosphorylation of myosin light chain and not ezrin/radixin/moesin proteins at the cleavage furrow. Oncogene (2000) 2.08

Phosphorylation of vimentin by Rho-associated kinase at a unique amino-terminal site that is specifically phosphorylated during cytokinesis. J Biol Chem (1998) 2.04

Identification of a Gs activator region of the beta 2-adrenergic receptor that is autoregulated via protein kinase A-dependent phosphorylation. Cell (1991) 1.74

Psychiatric morbidity in terminally ill cancer patients. A prospective study. Cancer (1996) 1.70

The phosphorylation of kinesin regulates its binding to synaptic vesicles. J Biol Chem (1992) 1.69

Roles of Rho-associated kinase in cytokinesis; mutations in Rho-associated kinase phosphorylation sites impair cytokinetic segregation of glial filaments. J Cell Biol (1998) 1.69

Regional cerebral blood flow during rewarming of cardiopulmonary bypass correlates with posthypothermic regional glucose use. J Thorac Cardiovasc Surg (1998) 1.60

Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain. Psychopharmacology (Berl) (2001) 1.60

Background factors and clinical symptoms of major depression with silent cerebral infarction. Stroke (1994) 1.47

Cell cycle regulation of human CDC6 protein. Intracellular localization, interaction with the human mcm complex, and CDC2 kinase-mediated hyperphosphorylation. J Biol Chem (1999) 1.47

Specific accumulation of Rho-associated kinase at the cleavage furrow during cytokinesis: cleavage furrow-specific phosphorylation of intermediate filaments. Oncogene (1999) 1.46

Degradation of c-Fos by the 26S proteasome is accelerated by c-Jun and multiple protein kinases. Mol Cell Biol (1995) 1.42

Hyperplastic callus formation in both femurs in osteogenesis imperfecta. Skeletal Radiol (1996) 1.42

Keratin attenuates tumor necrosis factor-induced cytotoxicity through association with TRADD. J Cell Biol (2001) 1.42

New method for evaluation of lung lymph flow rate with intact lymphatics in anaesthetized sheep. Acta Physiol (Oxf) (2006) 1.42

Development and validation of the cancer fatigue scale: a brief, three-dimensional, self-rating scale for assessment of fatigue in cancer patients. J Pain Symptom Manage (2000) 1.40

A psychosocial group intervention for Japanese women with primary breast carcinoma. Cancer (2000) 1.39

Coronary smooth muscle differentiation from proepicardial cells requires rhoA-mediated actin reorganization and p160 rho-kinase activity. Dev Biol (2001) 1.37

Humans can adopt optimal discounting strategy under real-time constraints. PLoS Comput Biol (2006) 1.36

Prevalence, predictive factors, and screening for psychologic distress in patients with newly diagnosed head and neck cancer. Cancer (2000) 1.35

Visualization and function of vimentin phosphorylation by cdc2 kinase during mitosis. J Biol Chem (1994) 1.34

Good death in cancer care: a nationwide quantitative study. Ann Oncol (2007) 1.34

Cell cycle- and chromatin binding state-dependent phosphorylation of human MCM heterohexameric complexes. A role for cdc2 kinase. J Biol Chem (1998) 1.32

A fourth type of rabbit protein kinase C. Biochemistry (1988) 1.32

Genetic progression and heterogeneity in intraductal papillary-mucinous neoplasms of the pancreas. Am J Pathol (1997) 1.29

Phosphorylation of glial fibrillary acidic protein at the same sites by cleavage furrow kinase and Rho-associated kinase. J Biol Chem (1997) 1.27

Visualization of mitotic radial glial lineage cells in the developing rat brain by Cdc2 kinase-phosphorylated vimentin. Glia (1998) 1.27

Psychological distress following first recurrence of disease in patients with breast cancer: prevalence and risk factors. Breast Cancer Res Treat (2000) 1.23

Protein kinases required for segregation of vimentin filaments in mitotic process. Oncogene (2001) 1.18

Domain- and sequence-specific phosphorylation of vimentin induces disassembly of the filament structure. Biochemistry (1989) 1.18

Histological and molecular evidence of synovial sarcoma of bone. A case report. J Bone Joint Surg Am (1999) 1.18

Activation of Rac by cadherin through the c-Src-Rap1-phosphatidylinositol 3-kinase-Vav2 pathway. Oncogene (2006) 1.17

Serotonin secretion from human platelets may be modified by Ca2+-activated, phospholipid-dependent myosin phosphorylation. J Biol Chem (1984) 1.14

Ultraviolet B-induced phosphorylation of histone H3 at serine 28 is mediated by MSK1. J Biol Chem (2001) 1.14

Interaction of smooth muscle myosin phosphatase with phospholipids. Biochemistry (1997) 1.13

Communication about the ending of anticancer treatment and transition to palliative care. Ann Oncol (2004) 1.13

Genetic classification of combined hepatocellular-cholangiocarcinoma. Hum Pathol (2000) 1.12

Sympathetic stimulation produces a greater increase in both transmural and spatial dispersion of repolarization in LQT1 than LQT2 forms of congenital long QT syndrome. J Am Coll Cardiol (2001) 1.12

Incidence of silent cerebral infarction in patients with major depression. Stroke (1993) 1.12

Phosphorylation of smooth muscle myosin light chain kinase by Ca2+-activated, phospholipid-dependent protein kinase. J Biol Chem (1985) 1.12

Factors correlated with fatigue in disease-free breast cancer patients: application of the Cancer Fatigue Scale. Support Care Cancer (2000) 1.12

N-(2-Aminoethyl)-5-isoquinolinesulfonamide, a newly synthesized protein kinase inhibitor, functions as a ligand in affinity chromatography. Purification of Ca2+-activated, phospholipid-dependent and other protein kinases. J Biol Chem (1985) 1.12

Specific localization of phosphointermediate filament protein in the constricted area of dividing cells. J Biol Chem (1991) 1.11

Balance between activities of Rho kinase and type 1 protein phosphatase modulates turnover of phosphorylation and dynamics of desmin/vimentin filaments. J Biol Chem (1999) 1.10

Development and validation of the Cancer Dyspnoea Scale: a multidimensional, brief, self-rating scale. Br J Cancer (2000) 1.10

Screening for psychological distress in Japanese cancer patients. Jpn J Clin Oncol (1998) 1.09

Truth-telling practice in cancer care in Japan. Ann N Y Acad Sci (1997) 1.09

Serum levels of IL-6 and IL-1β can predict the efficacy of gemcitabine in patients with advanced pancreatic cancer. Br J Cancer (2013) 1.09

Use of disposable stapler in operative cystogastrostomy for pancreatic pseudocyst. Hepatogastroenterology (2000) 1.07

Potential remedy against Echinococcus multilocularis in wild red foxes using baits with anthelmintic distributed around fox breeding dens in Hokkaido, Japan. Parasitology (2002) 1.07

Isolation of human immunodeficiency virus from a Japanese hemophilia B patient with AIDS. Jpn J Cancer Res (1987) 1.07

Antidepressant drug treatments induce glial cell line-derived neurotrophic factor (GDNF) synthesis and release in rat C6 glioblastoma cells. J Neurochem (2001) 1.06

Identification of Mrj, a DnaJ/Hsp40 family protein, as a keratin 8/18 filament regulatory protein. J Biol Chem (2000) 1.05

Psycho-oncology in Japan: history, current problems and future aspect. Jpn J Clin Oncol (1999) 1.05

MAP kinases mediate UVB-induced phosphorylation of histone H3 at serine 28. J Biol Chem (2001) 1.05

Immunohistochemical localization of phosphorylated glial fibrillary acidic protein in the prefrontal cortex and hippocampus from patients with schizophrenia, bipolar disorder, and depression. Brain Behav Immun (2001) 1.05

Mitosis-specific histone H3 phosphorylation in vitro in nucleosome structures. Eur J Biochem (1990) 1.04

Protein kinase C phosphorylation of desmin at four serine residues within the non-alpha-helical head domain. J Biol Chem (1989) 1.04

Soluble VCAM-1 induces chemotaxis of Jurkat and synovial fluid T cells bearing high affinity very late antigen-4. J Immunol (1998) 1.03

Fatigue in ambulatory patients with advanced lung cancer: prevalence, correlated factors, and screening. J Pain Symptom Manage (2001) 1.02

Two different protein kinases act on a different time schedule as glial filament kinases during mitosis. EMBO J (1992) 1.02

Plasma concentrations of interleukin-1beta, interleukin-6, soluble interleukin-2 receptor and tumor necrosis factor alpha of depressed patients in Japan. Neuropsychobiology (2001) 1.01

Attenuated left prefrontal activation during a verbal fluency task in patients with depression. Neuropsychobiology (2003) 1.01

Cytotoxic lavandulyl flavanones from Sophora flavescens. J Nat Prod (2000) 1.01

Diagnosis of synovial sarcoma with the reverse transcriptase-polymerase chain reaction: analyses of 84 soft tissue and bone tumors. Diagn Mol Pathol (1998) 1.01

Closed-loop identification of carotid sinus baroreflex transfer characteristics using electrical stimulation. Jpn J Physiol (2000) 1.00

The results of reduced-size liver transplantation, including split livers, in patients with end-stage liver disease. Transplantation (1992) 1.00

Clinical evaluation of a pasteurized factor XIII concentrate administration in Henoch-Schönlein purpura. Japanese Pediatric Group. Thromb Res (1989) 1.00

Psychiatric disorders in cancer patients: descriptive analysis of 1721 psychiatric referrals at two Japanese cancer center hospitals. Jpn J Clin Oncol (2001) 1.00

Increased pre-therapeutic serum vascular endothelial growth factor in patients with early clinical relapse of osteosarcoma. Br J Cancer (2002) 0.99

Naphthalenesulfonamides as calmodulin antagonists and protein kinase inhibitors. Mol Pharmacol (1986) 0.99

Identification of F344 rat hepatocytes transplanted within the liver of congenic analbuminemic rats by the polymerase chain reaction. Transplantation (1993) 0.98

Morphological and cytogenetic studies of a human synovial sarcoma xenotransplanted into nude mice. Acta Pathol Jpn (1990) 0.98

Why do some cancer patients with depression desire an early death and others do not? Psychosomatics (2001) 0.98

Differential regulation of aquaporin expression in astrocytes by protein kinase C. Brain Res Mol Brain Res (2001) 0.97

Modulation by sigma ligands of intracellular free Ca++ mobilization by N-methyl-D-aspartate in primary culture of rat frontal cortical neurons. J Pharmacol Exp Ther (1995) 0.97

Life-threatening dysphagia following prolonged neuroleptic therapy. Clin Neuropharmacol (1997) 0.97